Fatty Acids and Attention Deficit and Hyperactivity Disorder Symptoms

Attention Deficit Hyperactivity Disorder Clinical Trial

Official title:

Prenatal Omega-6/Omega-3 Ratio and Attention Deficit and Hyperactivity Disorder Symptoms in Children: a Population-based Longitudinal Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03283579
• Other study ID #: mlopez
• Status: Completed
• Start date: November 2003
• Est. completion date: December 2015

Study information

• Verified date: September 2017
• Source: Barcelona Institute for Global Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aimed to evaluate the longitudinal association between n-6:n-3 LCPUFAs ratio in cord blood and child ADHD symptoms at 4 and 7 years old. This study was based on the INMA project, a population-based birth cohort in Spain. Higher cord blood n-6:n-3 ratio was associated with higher subclinical ADHD symptoms during early and mid-childhood.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2644
• Est. completion date: December 2015
• Est. primary completion date: December 2015
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion criteria:

• Age 16 years or older

• Singleton pregnancy

• No use of assisted reproductive techniques

• Intention to deliver at the reference hospital

• Ability to speak and understand Spanish or a local language

Related Conditions & MeSH terms

• Attention Deficit Disorder with Hyperactivity
• Attention Deficit Hyperactivity Disorder
• Child Behavior Problem
• Disease
• Fatty Acid Deficiency
• Hyperkinesis
• Problem Behavior

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Barcelona Institute for Global Health

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Fatty acid ratio in cord blood		2004-2008
Primary	ADHD 4 years old		2008-2012
Primary	ADHD 7 years old		2012-2016